OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network
Sara Y. Tartof, Fagen Xie, Ruchi Yadav, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 5
Open Access | Times Cited: 16
Sara Y. Tartof, Fagen Xie, Ruchi Yadav, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 5
Open Access | Times Cited: 16
Showing 16 citing articles:
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez‐Baz, Noémie Sève, et al.
Eurosurveillance (2024) Vol. 29, Iss. 13
Open Access | Times Cited: 6
Charlotte Lanièce Delaunay, Iván Martínez‐Baz, Noémie Sève, et al.
Eurosurveillance (2024) Vol. 29, Iss. 13
Open Access | Times Cited: 6
Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort study
Altynay Shigayeva, Christopher Kandel, Lubna Farooqi, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Altynay Shigayeva, Christopher Kandel, Lubna Farooqi, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Clinical and laboratory features of COVID-19 in the vaccinated patients and the patients after previous illness
O.V. Riaba, Olga Golubovska
Ukrainian Scientific Medical Youth Journal (2025) Vol. 152, Iss. 1, pp. 38-46
Open Access
O.V. Riaba, Olga Golubovska
Ukrainian Scientific Medical Youth Journal (2025) Vol. 152, Iss. 1, pp. 38-46
Open Access
Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection
Julia C. Bennett, Kyle G Luiten, Jessica O’Hanlon, et al.
Vaccine (2024) Vol. 42, Iss. 6, pp. 1332-1341
Closed Access | Times Cited: 3
Julia C. Bennett, Kyle G Luiten, Jessica O’Hanlon, et al.
Vaccine (2024) Vol. 42, Iss. 6, pp. 1332-1341
Closed Access | Times Cited: 3
Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022
Kelsey M. Sumner, Ruchi Yadav, Emma K. Noble, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 1, pp. 45-54
Open Access | Times Cited: 3
Kelsey M. Sumner, Ruchi Yadav, Emma K. Noble, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 1, pp. 45-54
Open Access | Times Cited: 3
Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone
Abinash Virk, Matthew G. Johnson, Daniel Roellinger, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 8
Abinash Virk, Matthew G. Johnson, Daniel Roellinger, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 8
Trends in SARS-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia: A repeated cross-sectional survey, 2021–2022
Elizabeth Heilmann, Tannia Tembo, Sombo Fwoloshi, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 4, pp. e0003073-e0003073
Open Access | Times Cited: 2
Elizabeth Heilmann, Tannia Tembo, Sombo Fwoloshi, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 4, pp. e0003073-e0003073
Open Access | Times Cited: 2
Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions
Ruth Link‐Gelles, Amadea Britton, Katherine E. Fleming-Dutra
Vaccine (2023) Vol. 42, pp. 125492-125492
Open Access | Times Cited: 5
Ruth Link‐Gelles, Amadea Britton, Katherine E. Fleming-Dutra
Vaccine (2023) Vol. 42, pp. 125492-125492
Open Access | Times Cited: 5
Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections
Sung‐Gwon Lee, Priscilla A. Furth, Lothar Hennighausen, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109177-109177
Open Access
Sung‐Gwon Lee, Priscilla A. Furth, Lothar Hennighausen, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109177-109177
Open Access
Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders
Mohammad Yazdan Panah, Saeed Vaheb, Yousef Mokary, et al.
Vaccine (2024) Vol. 42, Iss. 23, pp. 126061-126061
Closed Access
Mohammad Yazdan Panah, Saeed Vaheb, Yousef Mokary, et al.
Vaccine (2024) Vol. 42, Iss. 23, pp. 126061-126061
Closed Access
Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022
Ryan Sandford, Ruchi Yadav, Emma K. Noble, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 7
Open Access
Ryan Sandford, Ruchi Yadav, Emma K. Noble, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 7
Open Access
Improved Methods for Vaccine Effectiveness Studies
George N. Okoli, Benjamin J. Cowling
The Journal of Infectious Diseases (2024)
Open Access
George N. Okoli, Benjamin J. Cowling
The Journal of Infectious Diseases (2024)
Open Access
ASSESSMENT OF MORTALITY RISKS FROM COVID-19 IN HOSPITALISED VACCINATED PATIENTS AND PATIENTS AFTER A PREVIOUS ILLNESS DEPENDING ON AGE
O.V. Riaba, Olga Golubovska, K. A. Chalyy
Medical Science of Ukraine (MSU) (2024) Vol. 20, Iss. 3, pp. 53-63
Open Access
O.V. Riaba, Olga Golubovska, K. A. Chalyy
Medical Science of Ukraine (MSU) (2024) Vol. 20, Iss. 3, pp. 53-63
Open Access
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021–June 2022
Kelsey M. Sumner, Ruchi Yadav, Emma K. Noble, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Kelsey M. Sumner, Ruchi Yadav, Emma K. Noble, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021—June 2022
Ryan Sandford, Ruchi Yadav, Emma K. Noble, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Ryan Sandford, Ruchi Yadav, Emma K. Noble, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
